PMC:7558914 / 10895-11155 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"255","span":{"begin":101,"end":119},"obj":"Chemical"},{"id":"256","span":{"begin":124,"end":143},"obj":"Chemical"},{"id":"257","span":{"begin":182,"end":200},"obj":"Chemical"},{"id":"258","span":{"begin":216,"end":228},"obj":"Chemical"},{"id":"259","span":{"begin":233,"end":252},"obj":"Chemical"}],"attributes":[{"id":"A255","pred":"tao:has_database_id","subj":"255","obj":"MESH:D006886"},{"id":"A256","pred":"tao:has_database_id","subj":"256","obj":"MESH:C558899"},{"id":"A257","pred":"tao:has_database_id","subj":"257","obj":"MESH:D006886"},{"id":"A258","pred":"tao:has_database_id","subj":"258","obj":"MESH:D017963"},{"id":"A259","pred":"tao:has_database_id","subj":"259","obj":"MESH:C558899"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"avir/ritonavir regimen 2 was the most recommended treatment (5/15, 33.3%). Different combinations of hydroxychloroquine and lopinavir/ritonavir (7/15, 46.7%) and triple therapy with hydroxychloroquine regimen 3, and azithromycin and lopinavir/ritonavir regimen"}